P15: Hematological adverse events as predictors of response to pegylated interferon and ribavirin treatment in patients with chronic hepatitis C genotype 4. (23rd October 2013) - Taha, A; Hasan, M; Samir, A; Kandil, A; El‐Sisi, E; Yilmaz, N